Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Sealong Biotechnology is a leading Chinese life sciences company specializing in the research, development, and industrial-scale production of organic acids and their derivatives. The company is recognized as one of the world's largest manufacturers of L-malic acid, DL-malic acid, and fumaric acid, serving the global food, beverage, and pharmaceutical sectors. Beyond food additives, Sealong produces high-purity pharmaceutical intermediates and excipients, including L-aspartic acid and various mineral malates used in clinical nutrition. Headquartered in Bengbu, Anhui, the company utilizes advanced bio-fermentation and chemical synthesis technologies to maintain its market leadership. Sealong is publicly traded on the National Equities Exchange and Quotations (NEEQ) and exports its products to over 60 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Sealong Biotechnology.